SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Work
Year: 2020
Type: article
Source: Cell
Institutions German Primate Center, University of Göttingen, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Freie Universität Berlin +7 more
Cites: 66
Cited by: 19,980
Related to: 10
FWCI: 473.6
Citation percentile (by year/subfield): 100
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze